Skip to main content
Clinical Trials/JPRN-UMIN000046316
JPRN-UMIN000046316
Completed
N/A

A Prospective Observational Study of clinical use of Imeglimin for type 2 diabetes mellitus - A Prospective Observational Study of clinical use of Imeglimin for type 2 diabetes mellitus

Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition0 sites30 target enrollmentDecember 10, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2021
End Date
January 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Allergy against imeglimin 2\) Severe ketosis, coma, type 1 diabetes 3\) Severe infection, surgery, injury 4\) eGFR \< 45 mL/min/1\.73m2 5\) Severe liver dysfunction (Child\-Pugh C) 6\) Subjects with pregnancy or lactation 7\) Use of Insulin 8\) Others who medical doctors judge as inappropriate subjects for imeglimin use.

Outcomes

Primary Outcomes

Not specified

Similar Trials